Medicines labeled for the same conditions
Alternatives to amlodipine and atorvastatin
72 other medicines are given the same way (oral) and in the same FDA class as amlodipine and atorvastatin or labeled mainly for the same use (high blood pressure); 15 are in its class, HMG-CoA reductase inhibitors: diltiazem, rosuvastatin, pravastatin, simvastatin and 11 more; the others include 15 angiotensin converting enzyme inhibitors, 10 beta-adrenergic blockers and 8 thiazide diuretics (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0321 per simvastatin 20 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as amlodipine and atorvastatin?
The first 24 of the 72, the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Amlodipine and atorvastatinHMG-CoA reductase inhibitor | this medicine | 6 labelers | $1.34 per unit 10-40 mg | No | No current entry |
| Diltiazemcalcium channel blocker · same class | High blood pressure, Angina | 42 labelers | $0.144 per capsule 24h ER(cd) 120 mg capsule | No | A presentation being discontinued |
| RosuvastatinHMG-CoA reductase inhibitor · same class | Heart attack and coronary artery disease, High cholesterol, High triglycerides, Stroke prevention | 46 labelers | $0.0692 per tablet 40 mg tablet | No | No current entry |
| PravastatinHMG-CoA reductase inhibitor · same class | Heart attack and coronary artery disease, High cholesterol, High triglycerides | 37 labelers | $0.058 per tablet 20 mg tablet | No | No current entry |
| SimvastatinHMG-CoA reductase inhibitor · same class | Heart attack and coronary artery disease, High cholesterol, High triglycerides | 27 labelers | $0.0321 per tablet 20 mg tablet | No | No current entry |
| Nifedipinedihydropyridine calcium channel blocker · same class | High blood pressure, Angina | 32 labelers | $0.130 per tablet 30 mg tablet | No | No current entry |
| Verapamilcalcium channel blocker · same class | High blood pressure, Angina | 24 labelers | $0.191 per tablet 180 mg tablet | No | A presentation being discontinued |
| LovastatinHMG-CoA reductase inhibitor · same class | Heart attack and coronary artery disease, High cholesterol | 19 labelers | $0.0436 per tablet 20 mg tablet | No | No current entry |
| Felodipinedihydropyridine calcium channel blocker · same class | High blood pressure | 14 labelers | $0.123 per tablet 5 mg tablet | No | No current entry |
| PitavastatinHMG-CoA reductase inhibitor · same class | High cholesterol | 12 labelers | $0.954 per tablet 2 mg tablet | No | No current entry |
| Ezetimibe and simvastatindietary cholesterol absorption inhibitor · same class | Heart attack and coronary artery disease, High cholesterol | 7 labelers | $0.285 per unit 10-80 mg | No | No current entry |
| Nicardipinedihydropyridine calcium channel blocker · same class | High blood pressure, Angina | 9 labelers | $1.12 per capsule 20 mg capsule | No | No current entry |
| FluvastatinHMG-CoA reductase inhibitor · same class | High cholesterol | 4 labelers | $2.88 per tablet 80 mg tablet | No | A presentation being discontinued |
| Nisoldipinedihydropyridine calcium channel blocker · same class | High blood pressure | 1 labeler | $5.24 per tablet 34 mg tablet | No | No current entry |
| Isradipinedihydropyridine calcium channel blocker · same class | High blood pressure | 3 labelers | $1.70 per capsule 5 mg capsule | No | No current entry |
| Trandolapril and verapamilcalcium channel blocker · same class | High blood pressure | 1 labeler | n/a | Yes | No current entry |
| Metoprololbeta-adrenergic blocker | High blood pressure, Angina, Heart attack and coronary artery disease | 64 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued |
| Lisinoprilangiotensin converting enzyme inhibitor | High blood pressure, Heart attack and coronary artery disease | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry |
| Propranololbeta-adrenergic blocker | High blood pressure, Angina | 38 labelers | $0.0493 per tablet 20 mg tablet | No | In shortage |
| Losartanangiotensin 2 receptor blocker | High blood pressure, Stroke prevention | 44 labelers | $0.0327 per tablet 50 mg tablet | Yes | No current entry |
| Clonidinecentral alpha-2 adrenergic agonist | High blood pressure | 37 labelers | $0.0241 per tablet 0.1 mg tablet | No | No current entry |
| Valsartanangiotensin 2 receptor blocker | High blood pressure | 34 labelers | $0.0963 per tablet 40 mg tablet | Yes | A presentation being discontinued |
| Atenololbeta-adrenergic blocker | High blood pressure, Angina, Heart attack and coronary artery disease | 35 labelers | $0.0217 per tablet 25 mg tablet | No | No current entry |
| Olmesartanangiotensin 2 receptor blocker | High blood pressure | 31 labelers | $0.0805 per tablet 20 mg tablet | Yes | No current entry |
| Labetalolbeta-adrenergic blocker | High blood pressure | 31 labelers | $0.215 per tablet 300 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Amlodipine and atorvastatin: the full record
- label, generics, price, shortages, recalls